versión imprimible
 
 

ARDS Drug Development Summit

Evvnt Promotion / evvnt
-
13.07.2021 - 15.07.2021  Virtual
Time: 7:55 am - 3:00 pm
 
Temas de la conferencia
The coronavirus pandemic has catapulted ARDS into the limelight and offered a once in a lifetime opportunity to meaningfully study large patient populations with homogenous disease – revolutionizing the notoriously challenging drug development landscape and widening the window of therapeutic opportunity to treat ARDS for the first time ever.
Organizador profesional (PCO)
Hanson Wade
Observaciones
Brochure: https://go.evvnt.com/745323-3?pid=4832

Speakers: Eric Jenkins, Senior Medical Director, Athersys, Melanie Kelly, Chief Scientific Officer, Tetra Biopharma and more
 

Información e inscripción:

https://go.evvnt.com/745323-0?pid=4832
Ms. Kaltrina Kastrati
 
Categorías
Medicina General, Salud Pública
Idioma
Inglés
Cuota del Congreso
Conference + Workshops Day - Industry Pricing: USD 2697.00, Conference Only - Industry Pricing: USD 1999.00, Conference + Workshops Day - Academic Pricing: USD 2397.00, Conference Only - Academic Pricing: USD 1799.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Centro per la Formazione Permanente e l'Aggiornamento del Personale del Servizio SanitarioAMREF - African Medical and Research FoundationHilfswerk AustriaAnästhesie in Entwicklungsländern e. V.European Public Health Association (EUPHA)Ärztekammer für WienCharité International AcademyCenter of Excellence